In 2019, Magliozzi et al. found significantly higher levels of sCD163, free hemoglobin, haptoglobin and fibrinogen in the CSF of MS patients with high cortical lesion load at diagnosis. The gene discussed is CD163; the disease is myeloid sarcoma.